Novel neuroleptics improve attentional functioning in schizophrenic patients: Ziprasidone and aripiprazole

CNS Spectrums

Volumn 2, Issue 8, 1997, Pages 56-59

  Serper, Mark R ^a,b   Chou, James C Y ^b,c  

^a HOFSTRA UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0002033818     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900005046     Document Type: Review

References (26)

1. Kraepelin E. Dementia Praecox and Paraphrenia. Edinburgh, Scotland: Livingston; 1913.
2. Bleuler E; Zinkin J, trans. Dementia Praecox, or the Group of Schizophrenias. New York, NY: International Universities Press; 1950.
3. Nuechterlein KH, Dawson M. Information processing and attentional functioning in the course of schizophrenic disorder. Schizophr Bull. 1984;10:160-203.
4. Oltmanns TF, Neale JM. Schizophrenic performance when distractors are present: attentional deficit or differential task difficulty? J Abnorm Psychol. 1975;84:205-209.
5. Harvey PD, Winters K, Weintraub S, Neale JM. Distractibility in children vulnerable to psychopathology. J Abnorm Child Psychol. 1981;90:298-304.
6. Cornblatt BA, Erlenmeyer-Kimling L. Global attentional deviance as a marker of risk for schizophrenia: specificity and predictive validity. J Abnorm Psychol. 1986;94:470-486.
7. Nuechterlein KH, Edell WS, Norris M, Dawson M. Attentional vulnerability indicators, thought disorder and negative symptoms. Schizophr Bull. 1986;12:408-426.
8. Serper MR. Visual controlled information processing resources and formal thought disorder in schizophrenia and mania. Schizophr Res. 1993;9:55-61.
9. Harvey PD, Docherty N, Serper MR, et al. Cognitive deficits and thought disorder II. An eight month follow-up study. Schizophr Bull. 1990;16:147-151.
10. Marder SR, Asarnow RF, Van Putten T. Information processing and neuroleptic response in acute and stabilized schizophrenic patients. Psychiatry Res. 1984;13:41-49.
11. Nestor PG, Faux SF, McCarley RW, Sands SF, Horvath TB, Peterson A. Neuroleptics improve sustained attention in schizophrenia: a study using signal detection theory. Neuropsychopharmacology. 1991;4:145-149.
12. Serper MR, Davidson M, Harvey PD. Attentional predictors of clinical change during neuroleptic treatment for schizophrenia. Schizophr Res. 1994;13:65-71.
13. Spohn HE, Lacoursiere RB, Thompson K, Coyne L. Phenothiazine effects on psychological and psychophysiological dysfunction in chronic schizophrenics. Arch Gen Psychiatry. 1977;34:633-644.
14. Rosvold HE, Mirsky A, Sarason I, Bransome ED, Beck LH. A continuous performance test of brain damage. Journal of Consulting Psychology (J Consult Clin Psychol). 1956;20:343-350.
15. Orzack MH, Kornetsky C, Freedman H. The effects of daily carphenazine on attention in the schizophrenic patient. Psychopharmacologia. 1967;11:31-38.
16. Oltmanns TF, Ohayon J, Neale JM. The effect of medication and diagnostic criteria on distractibility in schizophrenia. J Psychiatr Res. 1979;17:241-250.
17. Strauss ME, Lew MF, Coyle JT, Tune LE. Psychopharmacologic and clinical correlates of attention in chronic schizophrenia. Am J Psychiatry. 1985;142:497-499.
18. Serper MR, Bergman RL, Harvey PD. Medication may be required for the development of automatic information processing in schizophrenia. Psychiatry Res. 1990;32:281-288.
19. Serper MR, Davidson M, Harvey, PD Attentional and clinical neuroleptic response in schizophrenia: a study with the CPT. Cognitive Neuropsychiatry. In press.
20. Mirsky AF, Kornetsky C. The effect of centrally-acting drugs on attention. In: Efron DH, ed. Psychopharmacology. Bethesda, Md: Public Health Services; 1968.
21. Braff DL, Huey L. Methylphenidate-induced information processing deficits in nonschizophrenic patients. Arch Gen Psychiatry. 1988;45:827-832.
22. Cohen JD, Servan Schreiber D. A theory of dopamine function and its role in cognitive deficits in schizophrenia. Schizophr Bull. 1993;19:85-104.
23. Harvey PD, Serper MR. Linguistic and cognitive failures in schizophrenia. a Multivariate analysis. J Nerv Ment Dis. 1990;178:487-493.
24. 2 receptor and alpha. 1-adrenoceptor antagonism. J Clin Psychopharmacol. 1995;15:11S-18S.
25. Braff DL, Sacuzzo DP. Effects of antipsychotic medication on speed of information processing in schizophrenic patients. Am J Psychiatry. 1982;139:1127-1130.
26. Swerdlow NR, Koob GF. Dopamine, schizophrenia, mania and depression: forward and unified hypothesis of cortico-striato-pallido-thalamic function. Behavior and Brain Sciences. 1987;10:215-217.